官网资料介绍，合富集团是目前唯一一家两岸双上市的医疗企业，旗下合富医疗控股股份有限公司于台 湾证券柜台买卖中心上柜，合富（中国）医疗科技股份有限公司于上海证券交易所主板上市。 合富于2000年在上海成立运营总部。公司称，其创立是为了提升大中华医疗水平，期盼让所有的医院能 够拥有世界一流的医疗设备，使绝大部分人群可以享受到世界先进的医疗技术。一直以来，合富始终以 建构优质的医疗服务体系和促进大健康产业发展为使命，通过科技及服务模式的双创新，为医院提升竞 争力。 合富中国11月14日公告，自2025年10月28日至2025年11月14日期间，公司股票连续十四个交易日中有十 二个交易日以涨停价收盘，并5次触及股价异常波动、3次触及严重异常波动情形，期间累计涨幅高达 256.29%，已明显高于同期行业及上证指数涨幅。股价短期内连续上涨，存在市场情绪过热、非理性炒 作风险，随时存在快速下跌可能。为维护广大投资者利益，公司将就上述股票交易波动情况进行核查。 经向上海证券交易所申请，公司股票将于2025年11月17日（星期一）开市起停牌，自披露核查公告后复 牌。 本文系观察者网独家稿件，未经授权，不得转载。 ...

Core Viewpoint - The stock of China Aifu (603122) has experienced a significant increase, with a cumulative rise of 256.29% over a period of fourteen trading days, indicating potential market overheating and irrational speculation [1] Stock Performance - From October 28, 2025, to November 14, 2025, the company's stock closed at the daily limit price on twelve out of fourteen trading days [1] - The stock has encountered five instances of abnormal price fluctuations and three instances of severe abnormal fluctuations during this period [1] - The stock's performance has notably outpaced the industry and the Shanghai Composite Index [1] Trading Suspension - The company's stock will be suspended from trading starting November 17, 2025, with an expected suspension duration of no more than three trading days [1] - Trading will resume after the disclosure of the verification announcement [1]

Core Viewpoint - The stock of HeFu China (603122.SH) has experienced a significant increase, with a total rise of 256.29% over a period where it closed at the limit-up price for 12 out of 14 trading days, indicating potential market overheating and irrational speculation [1] Summary by Relevant Sections - **Stock Performance** - The stock price increased by 256.29% during the period from October 28, 2025, to November 14, 2025, with 12 out of 14 trading days closing at the limit-up price [1] - The stock has encountered 5 instances of abnormal price fluctuations and 3 instances of severe abnormal fluctuations during this period [1] - **Market Context** - The stock's performance has significantly outpaced the industry and the Shanghai Composite Index during the same timeframe [1] - **Trading Suspension** - The stock will be suspended from trading starting November 17, 2025, for a period not exceeding 3 trading days, pending the disclosure of a verification announcement [1]

Core Viewpoint - The stock of HeFu China has experienced a significant increase, with a cumulative rise of 256.29% over fourteen trading days, leading to a suspension of trading to assess the situation and mitigate risks for investors [1][4][5]. Group 1: Stock Performance - HeFu China's stock has closed at the涨停 price for twelve out of the last fourteen trading days, indicating a strong upward trend [1][4]. - The stock's cumulative increase of 256.29% is notably higher than the performance of the industry and the Shanghai Composite Index during the same period [1][4]. - On November 14, the stock reached a peak price of 23.8 yuan per share, with a trading volume exceeding 26 billion yuan, although it closed with a more modest increase of 7.69% [6]. Group 2: Trading Suspension - The company announced that its stock will be suspended from trading starting November 17, 2025, for a period not exceeding three trading days [1][5]. - The suspension is a response to the stock's rapid price increase and the potential for irrational market behavior, which could lead to a swift decline in stock value [4][5]. - The company has issued warnings regarding the significant deviation of the stock price from its fundamental performance, advising investors to be cautious [5].

公司已于2025年11月13日进一步提示，股价涨幅已严重显著偏离公司基本面，投资者参与交易可能面临 较大风险；如公司股价继续异常上涨，可能申请停牌核查。11月14日，公司股价继续大幅上涨，盘中一 度触及涨停，换手率高达28.48%。为维护广大投资者利益，根据《上海证券交易所上市公司自律监管 指引第4号——停复牌》《上海证券交易所股票上市规则》等相关规定，经向上海证券交易所申请，本 公司股票将于2025年11月17日（星期一）开市起停牌，预计停牌时间不超过3个交易日，公司股票将自 披露核查公告后复牌。公司提醒广大投资者注意二级市场交易风险。 格隆汇11月14日丨合富中国(603122.SH)公布，自2025年10月28日至2025年11月14日期间，公司股票连 续十四个交易日中有十二个交易日以涨停价收盘，并5次触及股价异常波动、3次触及严重异常波动情 形，期间累计涨幅高达256.29%，已明显高于同期行业及上证指数涨幅。股价短期内连续上涨，存在市 场情绪过热、非理性炒作风险，随时存在快速下跌可能。 ...

今日聚焦 1、14天12板合富中国：因股价短期内涨幅较大 公司股票将于11月17日起停牌核查 合富中国公告称，公司股票连续十四个交易日中有十二个交易日以涨停价收盘，累计涨幅高达 256.29%，已明显高于同期行业及上证指数涨幅。公司股票将于11月17日开市起停牌，预计停牌时间不 超过3个交易日。公司提醒投资者注意二级市场交易风险，当前股价与公司经营业绩、行业情况严重偏 离。 注：10月28日以来的14个交易日，合富中国收出了12个涨停。 1、上海机场：2025年10月浦东国际机场旅客吞吐量为752.04万人次，同比增长12.46% 2、海南机场：10月旅客吞吐量194.17万人次，同比增长5.01% 3、海航控股：10月旅客运输量同比增长3.59% 4、中国建筑：前10月新签合同额3.61万亿元 同比增长1% 5、中国中冶：前10月新签合同额8450.7亿元 同比下降11.8% 6、中煤能源：10月商品煤销量2188万吨 同比下降12.8% 7、中国神华：2025年10月商品煤产量2640万吨，同比下降7.4% 2、拓荆科技：11个员工持股平台合计减持1%公司股份 拓荆科技公告称，公司于2025年11月14日 ...

Core Viewpoint - The stock of HeFu China has experienced significant volatility, with a cumulative increase of 256.29% over the past fourteen trading days, outperforming both the industry and the Shanghai Composite Index. The company will suspend trading on November 17, with the suspension expected to last no more than three trading days, while cautioning investors about market risks due to the current stock price being misaligned with the company's operational performance and industry conditions [1]. Group 1 - HeFu China's stock has closed at the涨停 price for twelve out of the last fourteen trading days, indicating strong market interest [1]. - The company has issued multiple risk warnings in recent trading days, highlighting potential discrepancies between stock performance and underlying business fundamentals [4]. - The stock price reached 23.8 yuan per share with a trading volume exceeding 26 billion yuan on the last trading day before the suspension [4]. Group 2 - The trading suspension for HeFu China is categorized as an A-share suspension, starting on November 17, 2025 [3].

公告显示，自10月28日至11月14日期间，合富中国股票连续十四个交易日中有十二个交易日以涨停价收 盘，并5次触及股价异常波动、3次触及严重异常波动情形，期间累计涨幅高达256.29%，已明显高于同 期行业及上证指数涨幅。股价短期内连续上涨，存在市场情绪过热、非理性炒作风险，随时存在快速下 跌可能。 北京商报讯(记者丁宁)11月14日晚间，合富中国（603122）发布公告称，为维护广大投资者利益，根据 相关规定，经向上交所申请，公司股票将于11月17日开市起停牌，预计停牌时间不超过3个交易日，公 司股票将自披露核查公告后复牌。 ...

Group 1 - The core point of the article highlights that 合富中国's stock has experienced significant volatility, with a cumulative increase of 256.29% over a short period, leading to concerns about market overheating and irrational speculation [1] - The company has announced a temporary suspension of its stock trading starting November 17, 2025, due to the abnormal price fluctuations and to protect investor interests [1] - As of the latest report, 合富中国's market capitalization stands at 9.5 billion yuan, with its revenue composition heavily reliant on commercial activities, accounting for 99.96% of total revenue [2]

证券代码：603122 证券简称：合富中国 公告编号：临 2025-057 合富（中国）医疗科技股份有限公司 股票停牌核查公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 证券停复牌情况：适用 因合富（中国）医疗科技股份有限公司（以下简称"公司"）股票短期内股 价涨幅较大,本公司的相关证券停复牌情况如下： | 证券代码 | 证券简称 | 停复牌类型 | | 停牌起始日 | 停牌期间 | 停牌终止日 | 复牌日 | | --- | --- | --- | --- | --- | --- | --- | --- | | 603122 | 合富中国 | A 股 | 停牌 | 2025/11/17 | | | | 自 2025 年 10 月 28 日至 2025 年 11 月 14 日期间，公司股票连续十四个交易 日中有十二个交易日以涨停价收盘，并 5 次触及股价异常波动、3 次触及严重异常 波动情形，期间累计涨幅高达 256.29%，已明显高于同期行业及上证指数涨幅。股 价短期内连续上涨，存在市场情绪过热、非理性 ...